Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! 

China Clinical Trials 2017

Analysis of IND and NDA applications and approvals in China 2011-2017

Download free report on life science investment in China

More Time for Bayer-Topsun Deal

publication date: Mar 5, 2008

Topsun Science and Technology (SHA: 600771) has agreed to extend the deadline for the giant German pharmaceutical company Bayer AG (XE: 575200) to close its 1.26 billion RMB ($177 million) purchase of Topsun’s portfolio of OTC cold drugs. Bayer must now complete the purchase by June 30, 2008. When the acquisition had not closed in February 2008, Topsun announced Bayer was in danger of losing the deal, but a new agreement was signed on February 29, extending the deadline for four months. It is not clear what is keeping Bayer from completing the purchase. More details...

Stock Symbols:  (SHA: 600771) (XE: 575200)

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China